DIAVACS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2013-01-01
- Employees
- 51
- Market Cap
- -
- Website
- https://www.diavacs.com
Autologous Immunoregulatory Dendritic Cells for Type 1 Diabetes Therapy
Phase 2
Withdrawn
- Conditions
- Type 1 Diabetes
- Interventions
- Biological: Immunoregulatory Dendritic Cells
- First Posted Date
- 2015-02-03
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- DiaVacs, Inc.
- Registration Number
- NCT02354911
Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy
Phase 1
- Conditions
- Treatment of Type I Diabetes Mellitus.
- Interventions
- Biological: Biological
- First Posted Date
- 2013-09-20
- Last Posted Date
- 2013-10-23
- Lead Sponsor
- DiaVacs, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT01947569
- Locations
- 🇺🇸
UPMC, Pittsburgh, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath